GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...
GSK) share price is a nightmare and there’s little sign of respite for long-suffering investors. Shares in the FTSE 100 ...
Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...
GlaxoSmithKline (GSK) stock climbed on Thursday after the healthcare company announced that CEO Andrew Witty would retire in March 2017. GlaxoSmithKline (GSK) stock climbed on Thursday after the ...
Zacks.com on MSN2mon
Is GSK an Attractive Drug Stock to Add to Your Portfolio Now?Let's discuss these factors in detail to understand if GSK’s stock is worth buying now. GSK has more than 20 marketed ...
GET MORE AI-GENERATED SIGNALS: September 19, 2024, 20:16 pm ET, BY Jeff W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...
Zacks.com on MSN3d
GSK Meets Study Goal for Co-Administered RSV-Shingles VaccinesGSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...
Analyst Graham Parry from Bank of America Securities maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) and keeping the ...
The drug showed similar remission rates to GSK's Nucala. Vandana Singh GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older ...
Shares of GSK PLC GSK dropped 1.38% to £16.10 Tuesday, on what proved to be an all-around favorable trading session for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback